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Orthomolecular diagnosis is the process of determining and evaluating the concentrations of the substances normally present in the human body. This paper describes the general method that we are using for orthomolecular diagnosis. We believe that a significant improvement in health and a decrease in the age-specific morbidity and mortality from various diseases can be achieved by varying the concentrations in the body of the molecules that are normally present, many of which are required for life (1) . The corresponding field is described as "orthomolecular medicine." An important part of orthomolecular medicine, orthomolecular diagnosis, is the process of determining the concentrations of various substances in the human body (2) . We have studied some of the techniques for determining the amounts of different substances in body fluids. Most of our experiments on orthomolecular diagnosis have involved the use of gas-liquid chromatography, ion-exchange chromatography, or mass spectrometry.
In this paper we discuss the approach to this problem that we have developed during the past five years and discuss examples taken from the chromatographic experiments. In general, we have not required that our experiments be based on any particular biochemical mechanisms related to particular diseases. We Therefore, we have restricted these measurements in the effort to achieve the goal that the entire procedure can be offered to apparently well persons at a cost of $10 or less if it is found to be useful. eral points along the axis allows construction of a diagnostic power curve (3) as illustrated in Figure 4 . We take the diagnostic power of the method to be the ratio of the relative areas of area II to area I + II, as illustrated in Figure 4 . This ratio is chosen so as to avoid bias by those subjects who would be correctly diagnosed on a random basis, as illustrated by the diagonal line in Figure 4 . Figure 2 shows a computer plot of typical raw data from a urine analysis by the automated amino acid analyzer; Figure 3 illustrates the existence of a pattern in Stanford University students that is characteristic of sex. The corresponding diagnostic-power calculation is illustrated in Figure  4 . This diagnostic-power calculation was made with
Of) Mn 0 107A fl use of the 11 most strongly correlating peaks shown in Figure 3 while weighting the noncorrelation-index term for each of these peaks so that the strongest peak has a weight of 11, the next strongest a weight of 10, and so on to the least strongest with weight 1. Figure 5 illustrates the existence of a urinaryamine pattern characteristic of ingestion of birthcontrol pills. Figure 6 shows the failure of the procedure of urinary-amine analysis to detect a pattern characteristic of grade-point average in male Stanford students. Figure 7 shows a computer plot of a chromatogram from the procedure for urine-vapor analysis described in reference 10. This procedure was developed in the hope that the inclusion of a greater number of substances in the procedure would increase its diagnostic power. Figure 8 illustrates the greater number of substances available by this procedure.
Initial experiments have been carried out with urine-vapor analysis for comparison of several groups of subjects and appropriate control groups. Figures 9  through 13 show that the initial results of these experiments are quite promising.
We are convinced that the procedure is useful, and are now proceeding with the qualitative characterization of the unidentified substances in our patterns. One problem, however, remains unsolved. We have not proved that, for most of our sample groups, the only systematic property that contributes to the pattern for the group is that for which the group is labeled. We also have not shown how early the patterns for disease develop.
We do not know whether or not the patterns are present before the disease is extensively developed, and therefore are useful for preventive medicine.
To answer these questions, the Institute of Orthomolecular Medicine has initiated a program in which urine and serum samples will eventually be collected at six-month intervals from between 10 000 and 20 000 apparently well subjects. These samples will be stored indefinitely at -76 #{176}C. As time passes, some of the subjects in this group will become ill from various diseases. When sufficient numbers of subjects have become ill, the stored samples will allow rigorous elimination of individual variability and systematic sampling errors. It will also be possible to test properly for early patterns that indicate increased probability of sickness in well subjects.
In the meantime, we shall continue to adopt improved analytical procedures and to test these procedures with the best groups of samples that we are able to obtain, with special emphasis on the fluctuation of patterns with changes in therapy and disease severity.
When the experimental programs illustrated in Figures 1 through 13 
